SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-011554
Filing Date
2022-05-09
Accepted
2022-05-09 17:30:39
Documents
71
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20220331_10q.htm   iXBRL 10-Q 1110882
2 EXHIBIT 10.2 ex_364726.htm EX-10.2 18883
3 EXHIBIT 31.1 ex_349416.htm EX-31.1 16905
4 EXHIBIT 32.1 ex_349417.htm EX-32.1 9683
10 pipelinefy21.jpg GRAPHIC 30547
  Complete submission text file 0001437749-22-011554.txt   6019230

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220331.xsd EX-101.SCH 56339
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20220331_cal.xml EX-101.CAL 44406
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220331_def.xml EX-101.DEF 388184
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220331_lab.xml EX-101.LAB 339449
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220331_pre.xml EX-101.PRE 416891
65 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220331_10q_htm.xml XML 968166
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 22906357
SIC: 2836 Biological Products, (No Diagnostic Substances)